-
1
المؤلفون: Bradley R. Pieters, Fernanda G. Herrera, Antoine Engelen, Philippe Maingon, Santhanam Sundar, Christopher D Scrase, John Armstrong, Alphonsus C. M. van den Bergh, Ana Boladeras, Elzbieta van der Steen-Banasik, Michel Bolla, Amit Bahl, Laurence Collette, Christian Carrie, Joe M O'Sullivan, Demetrios Andreopoulos, Jihane Boustani, Annerie Slot, Anouk Neven, Jan Jansa, David Azria, Karine Peignaux-Casasnovas
المساهمون: EORTC Radiation Oncology Group, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Radiotherapy, CCA - Cancer Treatment and Quality of Life
المصدر: Journal of clinical oncology, vol. 39, no. 27, pp. 3022-3033
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(27), 3022-3033. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 39(27), 3022-3033. American Society of Clinical Oncologyمصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Disease, Androgen suppression, Radiation Dosage, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Risk Factors, Internal medicine, medicine, Humans, In patient, Aged, Aged, 80 and over, business.industry, Radiation dose, Cancer, Prostatic Neoplasms, Androgen Antagonists, Middle Aged, medicine.disease, 030104 developmental biology, 030220 oncology & carcinogenesis, Concomitant, business, Adjuvant
وصف الملف: application/pdf
-
2
المؤلفون: Gijs P A, van den Bergh, Malou C P, Kuppen, Hans M, Westgeest, Niven, Mehra, Winald R, Gerritsen, Katja K H, Aben, Inge M, van Oort, Reindert J A, van Moorselaar, Diederik M, Somford, Alfonsus J M, van den Eertwegh, André M, Bergman, Alphonsus C M, van den Bergh, Carin A, Uyl-de Groot
المصدر: Prostate cancer and prostatic diseases.
-
3
المؤلفون: Gijs P. A. van den Bergh, Malou C. P. Kuppen, Hans M. Westgeest, Niven Mehra, Winald R. Gerritsen, Katja K. H. Aben, Inge M. van Oort, Reindert J. A. van Moorselaar, Diederik M. Somford, Alfonsus J. M. van den Eertwegh, André M. Bergman, Alphonsus C. M. van den Bergh, Carin A. Uyl-de Groot
المساهمون: Urology, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, Internal medicine, Medical oncology, CCA - Cancer Treatment and quality of life, Epidemiology and Data Science, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Health Technology Assessment (HTA)
المصدر: Prostate Cancer and Prostatic Diseases. Nature Publishing Group
Prostate Cancer and Prostatic Diseases. SPRINGERNATURE
van den Bergh, G P A, Kuppen, M C P, Westgeest, H M, Mehra, N, Gerritsen, W R, Aben, K K H, van Oort, I M, van Moorselaar, R J A, Somford, D M, van den Eertwegh, A J M, Bergman, A M, van den Bergh, A C M & Uyl-de Groot, C A 2022, ' Incidence and survival of castration-resistant prostate cancer patients with visceral metastases : results from the Dutch CAPRI-registry ', Prostate Cancer and Prostatic Diseases . https://doi.org/10.1038/s41391-022-00605-7
Prostate Cancer and Prostatic Diseases, 26, 162-169
Prostate Cancer and Prostatic Diseases, 26, 1, pp. 162-169
Prostate Cancer and Prostatic Diseases, 26(1), 162-169. Nature Publishing Groupمصطلحات موضوعية: Cancer Research, All institutes and research themes of the Radboud University Medical Center, Oncology, SDG 3 - Good Health and Well-being, Urology, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], MEN, PART, PROGNOSTIC MODEL
وصف الملف: application/pdf
-
4
المؤلفون: Peter De Brouwer, Ben G. L. Vanneste, Flora E. van Leeuwen, J. Martijn Kerst, Sjoukje Lubberts, Alphonsus C. M. van den Bergh, Tineke J. Smilde, J. Alfred Witjes, Jourik A. Gietema, Berthe M.P. Aleman, Maureen J.B. Aarts, O. W. M. Meijer, Maarten C.C.M. Hulshof, Gerard Groenewegen, Simon Horenblas, Ronald de Wit, Katarzina Jóźwiak, Michael Schaapveld, Luca Incrocci, Hetty A van den Berg, Harmke J. Groot, Alexandra W. van den Belt-Dusebout
المساهمون: Radiotherapy, Medical Oncology, CCA - Cancer Treatment and Quality of Life, Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie, Promovendi ODB, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Radiation Oncology, Epidemiology and Data Science, APH - Quality of Care, CCA - Cancer Treatment and quality of life
المصدر: Groot, H J, Gietema, J A, Aleman, B M P, Incrocci, L, de Wit, R, Witjes, J A, Groenewegen, G, de Brouwer, P, Meijer, O W M, Hulshof, M C C M, van den Berg, H A, Smilde, T J, Vanneste, B G L, Aarts, M J, van den Bergh, A C M, Kerst, J M, van den Belt-Dusebout, A W, Lubberts, S, Jóźwiak, K, Horenblas, S, van Leeuwen, F E & Schaapveld, M 2018, ' Risk of diabetes after para-aortic radiation for testicular cancer ', British Journal of Cancer, vol. 119, no. 7, pp. 901-907 . https://doi.org/10.1038/s41416-018-0248-x
British Journal of Cancer, 119(7), 901-907. Nature Publishing Group
British journal of cancer, 119(7), 901-907. Nature Publishing Group
British Journal of Cancer, 119, 901-907
British Journal of Cancer
British Journal of Cancer, 119, 7, pp. 901-907مصطلحات موضوعية: Male, Cancer Research, Epidemiology, medicine.medical_treatment, Cohort Studies, MELLITUS, 0302 clinical medicine, GERM-CELL CANCER, Cancer Survivors, education.field_of_study, 030219 obstetrics & reproductive medicine, Incidence (epidemiology), Incidence, LONG-TERM SURVIVORS, Type 2 diabetes, 3. Good health, Treatment Outcome, Oncology, CARDIOVASCULAR-DISEASE, 030220 oncology & carcinogenesis, Cohort study, RADIOTHERAPY, Adult, medicine.medical_specialty, Diabetes risk, Population, Article, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Testicular cancer, Testicular Neoplasms, SDG 3 - Good Health and Well-being, Diabetes mellitus, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], SURVEILLANCE, medicine, Diabetes Mellitus, Humans, education, CARBOPLATIN, business.industry, Dose-Response Relationship, Radiation, STAGE-I SEMINOMA, medicine.disease, Confidence interval, Radiation therapy, business, FOLLOW-UP, A-REPORT, Orchiectomy
وصف الملف: application/pdf
-
5
المؤلفون: Igor Cordia, Joan van den Bosch, Hans M. Westgeest, Aad I. de Vos, Lidwine W. Tick, Ronald de Wit, Marco B. Polee, Maud M. Geenen, Alphonsus J. M. van den Eertwegh, Frank P. J. Peters, Mathijs P. Hendriks, Roan Spermon, Michiel O. Boerma, Carin A. Uyl-de Groot, Winald R. Gerritsen, Harrie P. Beerlage, Agnes J. van de Wouw, Alphonsus C. M. van den Bergh, Jules L.L.M. Coenen, Monique M.E.M. Bos, Reindert J.A. van Moorselaar, Pieter van den Berg, Haiko J. Bloemendal
المساهمون: CCA - Cancer Treatment and Quality of Life, CCA - Cancer Treatment and quality of life, Urology, Medical oncology, Health Technology Assessment (HTA), Medical Oncology
المصدر: European Urology Focus, 4(5), 694. Elsevier BV
European Urology Focus, 4, 694-701
European urology focus, 4(5), 694-701. Elsevier BV
European Urology Focus, 4(5), 694-701. Elsevier BV
European Urology, 4(5), 694-701. Elsevier
European Urology Focus, 4, 5, pp. 694-701
Westgeest, H M, Uyl-de Groot, C A, van Moorselaar, R J A, de Wit, R, van den Bergh, A C M, Coenen, J L L M, Beerlage, H P, Hendriks, M P, Bos, M M E M, van den Berg, P, van de Wouw, A J, Spermon, R, Boerma, M O, Geenen, M M, Tick, L W, Polee, M B, Bloemendal, H J, Cordia, I, Peters, F P J, de Vos, A I, van den Bosch, J, van den Eertwegh, A J M & Gerritsen, W R 2018, ' Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry ', European Urology Focus, vol. 4, no. 5, pp. 694-701 . https://doi.org/10.1016/j.euf.2016.09.008مصطلحات موضوعية: Male, Registry of outcomes, 030232 urology & nephrology, Docetaxel, Prostate cancer, 0302 clinical medicine, Medicine, Registries, Neoplasm Metastasis, Netherlands, Castration-resistant prostate cancer, Aged, 80 and over, education.field_of_study, Population based, Standard treatment, Incidence, Middle Aged, Tubulin Modulators, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Outcomes research, 030220 oncology & carcinogenesis, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], medicine.drug, medicine.medical_specialty, Registry, Urology, Population, Disease-Free Survival, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, Pragmatic Clinical Trials as Topic, Journal Article, Humans, Real-world outcomes, education, Aged, Retrospective Studies, business.industry, Proportional hazards model, Prostatic Neoplasms, medicine.disease, Clinical trial, Treatment, Trial population, Physical therapy, Observational study, business
وصف الملف: image/pdf; application/pdf